Table 15.
| Gender (%) | Male 38 (84%) Female 7 (16%) |
|
| |
| Cause of Liver Disease | |
| HBV | 18 |
| HCV | 19 |
| ETOH | 5 |
| Hemochrmatosis | 1 |
|
| |
| Age at Diagnosis | 62.8 years |
|
| |
| Average Survival after HCC Diagnosis | 28 months |
|
| |
| Average Survival after PVT Diagnosis | 15 months |
|
| |
| Total Patient 45 Anticoagulation No Yes Initial PVT Involvement Right PVT 18 (40%) Left PVT 13 (28%) Main PVT 6 (13%) Multi Involvement 8 (17%) |
PVT Progression 23 19 (49%) 4 (67%) 12 (67%) 7 (54%) 4 (67%) |
|
| |
| HCC type | |
| Single Lesion | 30 (67%) |
| Multifocal | 15 (33%) |
|
| |
| HCC Treatment Modality | |
| TACE | 19 (42%) |
| RFA | 3 (7%) |
| TACE + RFA | 8 (18%) |
| Systemic Treatment | 35 (78%) |
|
| |
| MELD Score (average) | 8.25 |
|
| |
| Child | A (71%), B (29%) |